Wellsim Biomedical Technologies Inc.

San Jose, CA

UEI
FD9MPD9K3EC1
CAGE
828F8
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Wellsim Biomedical Technologies Inc. is a for-profit small business that provides biomedical research and technology development services to federal agencies. According to SAM.gov, Wellsim is a self-certified small disadvantaged business focused on innovations in genomics, extracellular vesicles, and assay development platforms for applications in aging research and precision medicine.

Through prime federal grants from the National Institutes of Health, Wellsim Biomedical Technologies Inc. has developed novel platforms and assays to advance Alzheimer's disease diagnosis, extracellular vesicle isolation, single-cell multi-omics profiling, and COVID-19 testing. Specific services provided include a high-throughput immunofluorescence platform to detect Alzheimer's biomarkers, integrated approaches to link single-cell phenotypic data with gene expression profiles, microfluidic devices and workflows for extracellular vesicle purification and characterization, and clinical evaluations of rapid COVID-19 testing technologies. These research and technology development projects have been funded through the National Institute on Aging, National Human Genome Research Institute, National Institute of General Medical Sciences, and other groups within the NIH under programs supporting aging research, genomics, COVID-19 diagnostics, and more. As a subrecipient, Wellsim has also partnered with the University of Massachusetts Medical School to assess usability and performance of point-of-care COVID-19 testing devices.

Quick answers

Is Wellsim Biomedical Technologies Inc. registered in SAM.gov?

Wellsim Biomedical Technologies Inc.'s SAM.gov registration expired on August 13, 2026.

What is Wellsim Biomedical Technologies Inc.'s CAGE code?

Wellsim Biomedical Technologies Inc.'s CAGE code is 828F8, and its Unique Entity ID (UEI) is FD9MPD9K3EC1.

What is Wellsim Biomedical Technologies Inc.'s most recent federal award?

Wellsim Biomedical Technologies Inc.'s most recent federal grant award is Multi-omics profiling of individual exosomes for origin-tracing, biomarker discovery, and biological function… (R44GM145015), from National Institute of General Medical Sciences (NIH), on July 25, 2024.

On GovTribe

See Wellsim Biomedical Technologies Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe